Company intelligence / Profile preview

Mesosystem

Ownership: Private
Development stage: NDA

Overview

Mesosystem S.A., headquartered in Lisbon, Portugal, develops innovative medical cosmetic solutions with a particular emphasis on combating skin aging through projects like AgeTech.[3] The company operates globally with a portfolio that includes both pharmaceutical manufacturing and advanced cosmetic technologies.[5]

Therapeutic areas: Dermatology
Modalities: DeviceTopical formulation
Industry: Biotech

Drug pipeline

2 assets

remestemcel-L

NDA

Indications: Steroid-refractory acute graft versus host disease, Inflammatory bowel disease

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Mesosystem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mesosystem.

Explore the full profile